FR2652502B1 - Agent anti-virus du sida et medicaments therapeutiques ou preventifs utilisant cet agent. - Google Patents

Agent anti-virus du sida et medicaments therapeutiques ou preventifs utilisant cet agent.

Info

Publication number
FR2652502B1
FR2652502B1 FR8916237A FR8916237A FR2652502B1 FR 2652502 B1 FR2652502 B1 FR 2652502B1 FR 8916237 A FR8916237 A FR 8916237A FR 8916237 A FR8916237 A FR 8916237A FR 2652502 B1 FR2652502 B1 FR 2652502B1
Authority
FR
France
Prior art keywords
therapeutic
same
aids virus
virus agent
preventive drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8916237A
Other languages
English (en)
Other versions
FR2652502A1 (fr
Inventor
Kojima Eiji
Yoshioka Hidetoshi
Murakami Kunichika
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanyo Kokusaku Pulp Co Ltd
Original Assignee
Sanyo Kokusaku Pulp Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanyo Kokusaku Pulp Co Ltd filed Critical Sanyo Kokusaku Pulp Co Ltd
Publication of FR2652502A1 publication Critical patent/FR2652502A1/fr
Application granted granted Critical
Publication of FR2652502B1 publication Critical patent/FR2652502B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8916237A 1989-09-29 1989-12-08 Agent anti-virus du sida et medicaments therapeutiques ou preventifs utilisant cet agent. Expired - Fee Related FR2652502B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1254315A JPH0637391B2 (ja) 1989-09-29 1989-09-29 抗エイズウイルス剤

Publications (2)

Publication Number Publication Date
FR2652502A1 FR2652502A1 (fr) 1991-04-05
FR2652502B1 true FR2652502B1 (fr) 1993-12-24

Family

ID=17263292

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8916237A Expired - Fee Related FR2652502B1 (fr) 1989-09-29 1989-12-08 Agent anti-virus du sida et medicaments therapeutiques ou preventifs utilisant cet agent.

Country Status (6)

Country Link
US (1) US5580860A (fr)
JP (1) JPH0637391B2 (fr)
CA (1) CA2004784C (fr)
DE (1) DE3940551C2 (fr)
FR (1) FR2652502B1 (fr)
GB (1) GB2236251B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877222A (en) * 1996-07-19 1999-03-02 The Regents Of The University Of California Method for treating aids-associated dementia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ216172A (en) * 1985-05-15 1989-08-29 Wellcome Found Nucleosides and pharmaceutical compositions
IL85778A0 (en) * 1987-03-20 1988-09-30 Bristol Myers Co Production of 2',3'-dideoxynucleosides and certain such novel compounds
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
DE3739366A1 (de) * 1987-04-10 1988-10-27 Boehringer Mannheim Gmbh Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel
JP2619710B2 (ja) * 1989-02-27 1997-06-11 日本製紙 株式会社 ２′，３′−ジデオキシプリンヌクレオシド類の製造方法

Also Published As

Publication number Publication date
US5580860A (en) 1996-12-03
JPH03118324A (ja) 1991-05-20
CA2004784C (fr) 2000-05-02
DE3940551C2 (de) 1999-05-06
GB8927850D0 (en) 1990-02-14
GB2236251B (en) 1993-07-21
FR2652502A1 (fr) 1991-04-05
DE3940551A1 (de) 1991-04-11
CA2004784A1 (fr) 1991-03-29
JPH0637391B2 (ja) 1994-05-18
GB2236251A (en) 1991-04-03

Similar Documents

Publication Publication Date Title
NO874873L (no) Anordning for autoadministrering av fysiologisk aktive stoffer, med forhindring av overdosering.
MX9204301A (es) Acilmercaptoalcanoildipeptidos, metodos de preparacion y su uso terapeutico.
EP0831873A4 (fr) Therapie combinatoire pour le traitement d'infections virales vih et autres
NO911952L (no) Behandling av tilstander og sykdommer samt midler derfor.
DE69313097D1 (de) Chirurgische und/oder klinische vorrichtung.
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
EE9600139A (et) Farmatseutilised preparaadid ja ravimid endoteelsete düsfunktsioonide vältimiseks ja raviks
NO911429L (no) Stoffbehandling.
FR2735475B1 (fr) Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
FI101797B1 (fi) STLV-III-virukseen liittyvät polypeptidit, diagnostiset järjestelmät ja määritysmenetelmät
DE10075036I2 (de) Impfstoff und Diagnostikum f}r den Schweine-Cholera-Virus.
DE69021304D1 (de) Vorbeugendes und therapeutisches Mittel gegen Hepatitis.
ITVR940096A0 (it) Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
NO901396L (no) Fytosanitaere preparater, deres fremstilling og deres anvendelse for behandling av kryptogame sykdommer.
FR2675799B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
DE68906245D1 (de) Therapeutisches mittel gegen aids.
FR2652502B1 (fr) Agent anti-virus du sida et medicaments therapeutiques ou preventifs utilisant cet agent.
DE3773876D1 (de) Hochselektiver fallenkreis und benutzung eines solchen fallenkreises.
DE68909750D1 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
NO900635L (no) Herderblanding, samt anvendelse av den.
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
FI911638A0 (fi) Anordning foer soekning och stimulering av akupunkturstaellen.
TR25921A (tr) PESTISID ETKINLIGI HAIZ PESTISID ÖZELLIKTE BISIKLOOKTANLAR,BUNLARI IHTIVA EDEN FORMüLASYONLAR VE HAZIRLANMALARINA MAHSUS USULLER.

Legal Events

Date Code Title Description
TP Transmission of property
AU Other action affecting the ownership or exploitation of an industrial property right
TP Transmission of property
ST Notification of lapse